BCM
TGX

Bridgeway Capital Management’s THERAGENICS CORP TGX Stock Holding History

Bridgeway Capital Management’s Portfolio TGX Stock Details TGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-136,335
Closed -$297K – 1510
2013
Q3 		$297K Sell
136,335
-55,605
-29% -$119K 0.01% 1235
2013
Q2 		$397K Buy
+191,940
New +$343K 0.02% 1047

Bridgeway Capital Management's TGX Position: Q4 2013 in Review

Bridgeway Capital Management sold out of THERAGENICS CORP (TGX) in Q4 2013, closing a stake of 136,335 shares — an estimated $297K sold.

Bridgeway Capital Management first reported a position in TGX in Q2 2013 and held it in 2 quarters. The position peaked at $397K in Q2 2013. 0 funds tracked by Wall St. Rank hold TGX as of Q4 2013.

  • Bridgeway Capital Management reported no remaining THERAGENICS CORP position as of Q4 2013 after selling out during the quarter.
  • Bridgeway Capital Management sold 136,335 THERAGENICS CORP shares in Q4 2013, an estimated $297K.
  • Bridgeway Capital Management first reported a position in THERAGENICS CORP in Q2 2013 and held it in 2 quarters.
  • Bridgeway Capital Management's THERAGENICS CORP position peaked at $397K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held THERAGENICS CORP as of Q4 2013.

Based on Bridgeway Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.